Leadiant Biosciences, INC.
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$233Kgeneral payments (2019-2025)
$2,975research payments (2019-2025)
322clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Eric Brass | Torrance, CA | General Practice | $92,862.58 |
| Brian Schreiber | Neenah, WI | Internal Medicine | $48,600.00 |
| Bob Geng | San Diego, CA | Allergy & Immunology | $16,361.87 |
| Faruk Orge | Cleveland, OH | Ophthalmology | $14,636.52 |
| Monte Delmonte | Ann Arbor, MI | Ophthalmology | $8,749.34 |
| Stuart Goldstein | Cincinnati, OH | Pediatric Nephrology | $6,375.00 |
| Francesco Boin | West Hollywood, CA | Rheumatology | $3,500.00 |
| Laurence Greenbaum | Atlanta, GA | Pediatric Nephrology | $3,000.00 |
| Ewa Elenberg | Houston, TX | Pediatric Nephrology | $2,751.36 |
| Joshua Zaritsky | Phoenix, AZ | Pediatric Nephrology | $2,720.11 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.